Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunity against soft-tissue sarcomas.

Robert G Maki1

  • 1Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, Box 223, New York, NY 10021-6007, USA. makir@mskcc.org

Current Oncology Reports
|June 5, 2003
PubMed
Summary

Recent research shows that the immune system naturally responds to soft-tissue sarcomas. Scientists aim to amplify this natural immune response for effective cancer treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Concomitant Medication Effects on Immunotherapy Outcomes in Sarcoma: A Pooled Post Hoc Analysis of Seven Phase II Trials.

Cancer medicine·2026
Same author

Brigimadlin Versus Doxorubicin in Advanced Dedifferentiated Liposarcoma: Efficacy, Safety and Translational Data from Brightline-1, a Randomized Phase 2/3 Trial.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Cancer chemo-immunotherapy: time will tell.

Cancer immunology research·2026
Same author

Phase 2 study of palbociclib plus retifanlimab in patients with advanced dedifferentiated liposarcoma.

Journal for immunotherapy of cancer·2026
Same author

Multi-Omic Landscape of Gastrointestinal Stromal Tumors in a Real-World Patient Cohort of 1,427 Cases.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Trabectedin and low-dose irinotecan to target EWS::FLI1 in Ewing sarcoma: a phase 1/2 trial.

Nature medicine·2026

Area of Science:

  • Medical Science
  • Immunology
  • Oncology

Background:

  • Advances in understanding sarcoma molecular characteristics and immune system responses.
  • Novel technologies enhance appreciation of antigen-specific immune responses.
  • The intersection of immunology and sarcoma biology is increasingly evident.

Purpose of the Study:

  • To review initial evidence of immune responses against sarcomas.
  • To contextualize findings within current and potential clinical studies.
  • To explore the potential for amplifying anti-sarcoma immune responses.

Main Methods:

  • Review of recent advances in basic medical sciences.
  • Analysis of novel technologies in immunology.
  • Examination of data on immune responses in sarcoma patients.

Main Results:

  • A detectable autologous immune response against soft-tissue sarcomas exists.
  • Understanding of sarcoma biology and immune interactions is growing.
  • Hints of tumor-specific immune responses are being investigated.

Conclusions:

  • The immune system mounts a response against sarcomas.
  • Further research aims to amplify this response for therapeutic benefit.
  • Clinical studies are exploring the potential of immunotherapy for sarcomas.

Related Experiment Videos